ACB Calculator UK – Anticholinergic Burden Score

ACB Score Calculator

Select the medications your patient is currently taking to calculate their total Anticholinergic Cognitive Burden score. This calculator helps identify patients at risk of cognitive impairment, falls, and other adverse effects.

No medications selected. Choose from the list above.

How to Use This Calculator

Step 1: Browse or search for medications in the list above. You can type the medication name in the search box to find it quickly.
Step 2: Click on medications to select them. Selected medications will appear in the blue panel and show their individual ACB scores.
Step 3: Click the “Calculate ACB Score” button to see the total burden and personalised recommendations.
Step 4: Review the results carefully. Scores of 3 or more require clinical attention and possible medication review.

What Does Your Score Mean?

Score Range Risk Level Clinical Action
0 No anticholinergic burden No specific action needed. Continue routine monitoring.
1-2 Minimal to low burden Monitor for side effects. Consider during regular medication reviews.
3-5 Moderate burden Review medications promptly. Discuss alternatives with prescriber.
6+ High burden Urgent medication review required. High risk of adverse outcomes.

Research shows that patients over 65 with an ACB score of 3 or higher face significantly increased risks. A study of 13,004 older patients found that 20% of those with scores of 4 or more died within two years, compared to just 7% of those with zero scores. Each additional ACB point increases mortality risk by approximately 26%.

Why ACB Matters for Older Adults

Anticholinergic medications block acetylcholine, a crucial neurotransmitter in your brain and nervous system. Acetylcholine helps with memory, learning, alertness, and many body functions like bladder control and heart rate regulation.

When you take multiple medications with anticholinergic properties, their effects add up. This cumulative burden can cause:

  • Memory problems and confusion
  • Increased risk of falls and fractures
  • Blurred vision and dry mouth
  • Constipation and urinary retention
  • Long-term cognitive decline and dementia risk
  • Higher mortality rates in older populations

People over 55 who take strong anticholinergic medicines for three years or more show increased dementia risk. The elderly are particularly vulnerable because the blood-brain barrier becomes more permeable with age, allowing more medication to affect brain function.

Common Medications with High ACB Scores

Many widely prescribed medications carry significant anticholinergic burden. Here are the main categories:

Medication Class Common Examples Typical ACB Score
Tricyclic Antidepressants Amitriptyline, Nortriptyline, Dosulepin 3
Bladder Control Medicines Oxybutynin, Tolterodine, Solifenacin 3
First-Generation Antihistamines Chlorphenamine, Diphenhydramine, Hydroxyzine 3
Antipsychotics Olanzapine, Quetiapine, Chlorpromazine 2-3
Muscle Relaxants Cyclobenzaprine, Orphenadrine 3

What catches many people off guard is that even medications with lower scores can add up. Drugs like certain painkillers, antihistamines, and stomach medicines may each score only 1 point, but taking several together creates significant burden.

Frequently Asked Questions

Should I stop my medications if my ACB score is high?
Never stop medications without consulting your GP or pharmacist first. Many anticholinergic medicines require gradual withdrawal to avoid withdrawal symptoms like anxiety, nausea, and dizziness. Your healthcare provider can create a safe deprescribing plan and suggest alternatives.
Can younger people have problems with anticholinergic medications?
Whilst the evidence is strongest for people over 65, anyone can experience side effects from anticholinergic medications. However, older adults face higher risks due to age-related changes in metabolism, kidney function, and blood-brain barrier permeability.
Are all ACB calculators the same?
Different ACB scales exist, including the Anticholinergic Cognitive Burden Scale, German Anticholinergic Burden score, and others. They sometimes rate medications differently based on their methodology. NICE guidance states there is insufficient evidence to recommend one scale over others, so most calculators use combined approaches for safety.
What if I need my high-ACB medication for a specific condition?
Some conditions require anticholinergic medications, particularly in specialist areas like Parkinson’s disease management. In these cases, your specialist will weigh the benefits against risks. The goal is to use the lowest effective dose and minimise other anticholinergic medications where possible.
How often should ACB scores be checked?
ACB scores should be calculated whenever new medications are added and reviewed at least annually for older adults. More frequent reviews are appropriate for patients with dementia, those who have fallen, or those experiencing confusion or cognitive changes.
Can reducing ACB improve my symptoms?
Yes! Studies show that reducing anticholinergic burden can improve short-term memory, reduce confusion, decrease delirium episodes, and improve overall functioning. Some patients also find they can stop other medications that were managing side effects of anticholinergics.
What alternatives exist to high-ACB medications?
Many conditions have alternative treatments with lower anticholinergic burden. For depression, SSRIs like citalopram or sertraline have lower scores than tricyclics. For allergies, third-generation antihistamines like fexofenadine have minimal anticholinergic effects. For bladder problems, lifestyle modifications or mirabegron (a different class of medicine) might be options.

NICE Guidance on Anticholinergic Burden

The National Institute for Health and Care Excellence has incorporated anticholinergic burden awareness into several clinical guidelines:

  • Dementia (NG97): Clinicians should minimise medicines with anticholinergic burden when assessing suspected dementia, as high ACB can mimic dementia symptoms. Regular medication reviews are essential for people living with dementia.
  • Falls in Older People (CG161): Medication review is recommended as part of multifactorial fall risk assessment, with particular attention to psychotropic and anticholinergic medications.
  • Urinary Incontinence in Women (2019): Prescribers should consider the uncertainty around long-term cognitive effects when prescribing anticholinergic medicines for overactive bladder.

These guidelines reflect growing recognition that anticholinergic burden significantly impacts patient outcomes and should influence prescribing decisions across multiple conditions.

Reducing Your Anticholinergic Burden

If your ACB score is concerning, here are steps to take:

  • Request a medication review: Ask your GP or pharmacist to review all your medicines, including over-the-counter products and supplements.
  • Discuss each medication’s necessity: Some medicines prescribed years ago might no longer be needed.
  • Explore alternatives: Many conditions have treatment options with lower anticholinergic effects.
  • Consider non-drug approaches: Lifestyle changes, physiotherapy, or psychological therapies might reduce medication needs.
  • Plan gradual withdrawal: If stopping anticholinergic medicines, work with your prescriber on a tapering schedule to minimise withdrawal effects.
  • Monitor for improvements: Keep track of any changes in memory, alertness, or physical function as medications are adjusted.
Important Notice: This calculator is designed for healthcare professionals and informed patients. It provides guidance but does not replace professional medical advice. Always consult qualified healthcare providers before making medication changes. In emergencies, contact 999 or visit A&E immediately.

When Anticholinergics Interact with Dementia Treatment

A particularly important consideration: anticholinergic medications directly oppose the action of dementia treatments called acetylcholinesterase inhibitors (donepezil, galantamine, and rivastigmine). These dementia medicines work by increasing acetylcholine in the brain, whilst anticholinergics block it.

Prescribing both together is counterproductive and can worsen cognitive symptoms. If you or someone you care for is taking dementia medication, minimising anticholinergic burden becomes even more critical.

References

Boustani M, Campbell N, Munger S, Maidment I, Fox C. Impact of anticholinergics on the aging brain: a review and practical application. Aging Health. 2008;4(3):311-320.
Fox C, Richardson K, Maidment ID, et al. Anticholinergic Medication Use and Cognitive Impairment in the Older Population: The Medical Research Council Cognitive Function and Ageing Study. Journal of the American Geriatrics Society. 2011;59(8):1477-1483.
Coupland CAC, Hill T, Dening T, Morriss R, Moore M, Hippisley-Cox J. Anticholinergic Drug Exposure and the Risk of Dementia: A Nested Case-Control Study. JAMA Internal Medicine. 2019;179(8):1084-1093.
National Institute for Health and Care Excellence. Dementia: assessment, management and support for people living with dementia and their carers. NICE guideline [NG97]. 2018. Available at: https://www.nice.org.uk/guidance/ng97
National Institute for Health and Care Excellence. Falls in older people: assessing risk and prevention. Clinical guideline [CG161]. 2013. Available at: https://www.nice.org.uk/guidance/cg161
Campbell NL, Maidment I, Fox C, Khan B, Boustani M. The 2012 Update to the Anticholinergic Cognitive Burden Scale. Journal of the American Geriatrics Society. 2013;61(S1):S142-S143.
Rudolph JL, Salow MJ, Angelini MC, McGlinchey RE. The Anticholinergic Risk Scale and Anticholinergic Cognitive Burden Scale. Archives of Internal Medicine. 2008;168(5):508-513.
Salahudeen MS, Duffull SB, Nishtala PS. Anticholinergic burden quantified by anticholinergic risk scales and adverse outcomes in older people: a systematic review. BMC Geriatrics. 2015;15:31.
Scroll to Top